According to the recent research report titled ‘Europe Protein A Resins Market Growth By Product, Application, Matrix Type, End-use, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2020 – 2026’, available with Market Study Report, Europe protein A resins market is projected surpass a valuation of USD 232 million by the year 2026.
 

Surging demand for chromatography for the discovery and purification of biological entities is likely to drive the growth of Europe protein A resins market. Notably, protein A resins are used in chromatography technique owing to its cost-effective, improved, & largely accepted component for purification of biological samples. Rising product approvals of monoclonal antibodies in order to meet burgeoning demand for immunotherapy is contributing to the overall market growth.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2609894/
 

Expansion of pharmaceutical and biotechnology companies is positively impacting Europe protein A resins market trends. Increasing funding towards protein-based research is also fueling the market growth. However, availability of alternatives like capillary electrophoresis, ultrafiltration, high pressure folding, and ultrafiltration for purification techniques may hamper the industry expansion in the forthcoming years.
 

Elaborating on product type, recombinant segment accounted for USD 80 million in the year 2019. Shifting preferences towards adopting recombinant protein A resins since other production sources provide low non-specific binding is fueling the segmental share.
 

Speaking of application spectrum, antibody purification segment of Europe protein A resins industry held 77% revenue share in the year 2019. Rising cases of chronic disorders such as rheumatoid arthritis has led to an upsurge in development of protein A resins kits for purifying antibodies among diagnostic and structural studies.
 

Further, monoclonal antibodies provide favorable results while managing chronic conditions including rheumatoid arthritis and cancer. Thus, advantages and widespread applications of antibodies is creating lucrative growth prospects for Europe protein A resins market.
 

Based on matrix type, Europe protein A resins industry from agro-based matrix segment is projected to register a CAGR of 8.3% through 2026. High flow rate, favorable pH conditions, and suitable resolution is adding momentum to the segmental growth.
 

Citing the end-use spectrum, biopharmaceutical segment is predicted to record 8.4% CAGR over the forecast timespan. Surging demand for drug development along with rising R&D expenditure is fostering the segmental share. Growing adoption of protein A resins by biotechnology industries for antibody production is also favoring the market outlook in Europe.
 

Citing the regional landscape, Germany held majority share in the year 2019 and is estimated to grow substantially over the study period. On the other hand, UK protein A resins industry is expected to record a CAGR of 7.5% over the analysis period. The growth is credited to high concentration of leading firms and rising number of pharmaceutical sectors in the region.
 

Major contenders in Europe protein A resins market are Tosoh Bioscience LLC, Takara Bio Inc., Sigma-Aldrich Corporation, Repligen, Purolite Life Sciences, Novasep SAS, GenScript Corporation, Expedeon Ltd., Danaher Corporation, Agarose Bead Technologies, Bio-Rad Laboratories, GE Healthcare, EMD Millipore, and Thermo Fisher Scientific among others.